Alpine Immune Sciences to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update

Rhea-AI Summary

Alpine Immune Sciences, Inc. (NASDAQ:ALPN) will release its fourth quarter and full year 2020 financial results on March 18, 2021, after market close. The company will host a conference call and live webcast at 4:30 p.m. ET to discuss the results and provide a corporate update. Investors can access the call via phone or through a webcast on the company's investor relations page. A replay will be available for 90 days post-event. Alpine aims to lead in immunotherapy with a strong R&D platform and collaborations in the biopharmaceutical sector.

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced the company will release fourth quarter and full year 2020 financial results on Thursday, March 18, 2021 after the close of market. Alpine will host a corresponding conference call and live webcast at 4:30 p.m. ET/1:30 p.m. PT on the same day to discuss the results and provide a corporate update.

Conference Call and Webcast Details

To access the live call by phone, dial (800) 816-3005 (domestic) or (857) 770-0069 (international) and reference conference ID: 2539338. A live webcast of the presentation will be available online in the investor relations section of the company’s website at https://ir.alpineimmunesciences.com/events. A replay of the presentation will be available on the company website for 90 days following the webcast.

About Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc. is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine endeavors to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com. Follow @AlpineImmuneSci on Twitter and LinkedIn.

“Secreted Immunomodulatory Proteins,” “SIP,” “Transmembrane Immunomodulatory Protein,” “TIP,” “Variant Ig Domain,” “vIgD” and the Alpine logo are registered trademarks or trademarks of Alpine Immune Sciences, Inc. in various jurisdictions.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210311005818/en/

FAQ

When will Alpine Immune Sciences release its financial results for Q4 and full year 2020?

Alpine Immune Sciences will release its financial results on March 18, 2021.

What time is the conference call for Alpine Immune Sciences' financial results?

The conference call is scheduled for 4:30 p.m. ET on March 18, 2021.

How can I access the webcast for Alpine Immune Sciences' financial results?

You can access the live webcast on the investor relations section of Alpine Immune Sciences' website.

Will there be a replay of the Alpine Immune Sciences financial results call?

Yes, a replay of the presentation will be available on the company's website for 90 days.